BBLG

Bone Biologics Corp

NASDAQ: BBLG · HEALTHCARE · BIOTECHNOLOGY

$0.90

-5.89% today

Updated 2026-07-29

Market cap

$1.97M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.16

Dividend yield

—

52W range

$1 – $4

Volume

0.1M

Market cap

$1.97M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.16

Dividend yield

—

52W range

$1 – $4

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.5

Quality

3.0

Profitability

5.0

Valuation

C+

4/9

Piotroski F-Score

Moderate

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$12.20

+1248.66%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-804282.00

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-1.48M	$-8.95M	$-4.11M	$-3.11M	$-765988.00
EPS	—	—	—	—	$-1.16
Free cash flow	$-3.57M	$-9.56M	$-4.12M	$-2.69M	$-804282.00
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
BBLG	$1.97M	26	4.3	3.0	5.0	6.5	—	Avoid
LLY	$1.02T	76	10.0	10.0	4.3	6.0	—	Strong Buy
JNJ	$615.36B	57	4.7	8.5	4.3	6.0	—	Buy
ABBV	$447.53B	63	4.0	8.0	4.7	5.0	-78.83%	Buy
UNH	$391.69B	62	7.3	5.5	4.0	6.0	-30.51%	Buy
MRK	$307.25B	50	3.3	8.0	2.7	5.0	-62.28%	Hold

Smart narrative

Bone Biologics Corp trades at $0.90. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score.

Frequently asked questions

What is Bone Biologics Corp's stock price?

Bone Biologics Corp (BBLG) trades at $0.90.

Is Bone Biologics Corp overvalued?

Bone Biologics Corp carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Bone Biologics Corp (BBLG)?

The 12-month analyst consensus target is $12.20, about 1248.7% above the current $0.90. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-61.20%

Beta0.53

50D MA$1.30

200D MA$1.53

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

BBLG vs LLY →BBLG vs JNJ →BBLG vs ABBV →Stock screener →